Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06279039
Other study ID # KY20230116-06
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date December 31, 2024

Study information

Verified date February 2024
Source Nanjing First Hospital, Nanjing Medical University
Contact jie Dai
Phone 02552271117
Email karry_dj@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the goal of this half-face controlled study is to evaluate the effect of exosome-containing liquid dressings on the recovery of patients after Nd:YAG laser 532 treatment.


Description:

The main objective was to collect patients with fleae or seborrheic keratosis after Q-switched laser treatment, and then to use exosomes or matrix on both sides of the face, and finally to evaluate the effect of exosomes on wound healing and prevention of post-inflammatory hyperpigmentation after Nd:YAG laser 532 treatment


Recruitment information / eligibility

Status Recruiting
Enrollment 38
Est. completion date December 31, 2024
Est. primary completion date August 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - It meets the diagnostic criteria of seborrheic keratosis or freckle; - pepole are able to follow the treatment rules of the study and were followed up for 8 weeks; - informed consent Exclusion Criteria: - History of keloids ; - Pregnancy or lactation; - Any cosmetics containing growth factor-related ingredients used within 6 months prior to treatment - Patients with incomplete observation data and incomplete course of treatment were excluded

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Exosome liquid dressing
This study mainly adopted a randomized double-blind self-half face control method. The double-blind method was that the subjects and researchers did not know the experimental group and the control group. 38 sets of matched use sets (left and right, only the manufacturer knew the specific ingredients) were respectively applied to both sides of the cheeks of patients after Q-switched laser. The blind was unblinded after the experiment.

Locations

Country Name City State
China Jie Dai Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Nanjing First Hospital, Nanjing Medical University

Country where clinical trial is conducted

China, 

References & Publications (11)

An Y, Lin S, Tan X, Zhu S, Nie F, Zhen Y, Gu L, Zhang C, Wang B, Wei W, Li D, Wu J. Exosomes from adipose-derived stem cells and application to skin wound healing. Cell Prolif. 2021 Mar;54(3):e12993. doi: 10.1111/cpr.12993. Epub 2021 Jan 17. — View Citation

Aurangabadkar SJ. Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Indian J Dermatol Venereol Leprol. 2019 Jan-Feb;85(1):10-17. doi: 10.4103/ijdvl.IJDVL_1086_16. — View Citation

Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006 Apr;24(4):150-4. doi: 10.1016/j.tibtech.2006.01.010. Epub 2006 Feb 20. — View Citation

Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. A controlled, single-impact, dose-response, multicenter trial. Arch Dermatol. 1994 Dec;130(12):1515-9. — View Citation

Kim J, Kim B, Kim S, Lee YI, Kim J, Lee JH. The effect of human umbilical cord blood-derived mesenchymal stem cell media containing serum on recovery after laser treatment: A double-blinded, randomized, split-face controlled study. J Cosmet Dermatol. 2020 — View Citation

Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004 Jun;36(6):1031-7. doi: 10.1016/j.biocel.2003.12.003. — View Citation

Polla LL, Margolis RJ, Dover JS, Whitaker D, Murphy GF, Jacques SL, Anderson RR. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol. 1987 Sep;89(3):281-6. doi: 10.1111/1523-1747.ep12471397. — View Citation

Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998 Aug;176(2A Suppl):26S-38S. doi: 10.1016/s0002-9610(98)00183-4. — View Citation

Theoret CL. The pathophysiology of wound repair. Vet Clin North Am Equine Pract. 2005 Apr;21(1):1-13. doi: 10.1016/j.cveq.2004.11.001. — View Citation

Toyserkani NM, Christensen ML, Sheikh SP, Sorensen JA. Adipose-Derived Stem Cells: New Treatment for Wound Healing? Ann Plast Surg. 2015 Jul;75(1):117-23. doi: 10.1097/SAP.0000000000000083. — View Citation

Zoumalan CI. Topical Agents for Scar Management: Are They Effective? J Drugs Dermatol. 2018 Apr 1;17(4):421-425. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Global Aesthetic Improvement Scale score The treating physician evaluated the patient's improvement, which was divided into four levels: very improved corresponding, substantial improvement, improvement, no change; Corresponding to the best beauty results, significantly improved but not the best, significantly improved, no change 1, 3.5, 7, 14, 28, and 56 days
Primary Dermatology Quality of life index By answering multiple questions, patients self-rated the impact of their current illness on their lives within a week and scored. The answers were graded on four levels, very serious 3, very serious 2, a little 1, and no 0 1, 3.5, 7, 14, 28, and 56 days
Secondary post-inflammatory hyperpigmentation At 2, 4 and 8 weeks of follow-up, melanin index was measured by memetreter (memetreter MX18 cuttometer Dual MPA580, EnviroDerm Services (UK) Ltd) at the same follow-up. Objective evaluation of PIH. 2.4,8 weeks
See also
  Status Clinical Trial Phase
Completed NCT04698239 - Clinical Evaluation of the Safety and Benefits of the Milesman 445 nm Blue Laser on Inflammatory Acne Lesions. N/A
Not yet recruiting NCT03688737 - Low Level Laser in Isolated Cleft Palate Repair Versus Surgical Correction Without LLL in Healing Process N/A
Completed NCT04136652 - Vaginal CO2 Laser for Stress Incontinence N/A
Completed NCT03169517 - Blood Flow Index as an Indicator of Successful Peripheral Nerve Block N/A
Recruiting NCT06382805 - Comparison of the Effects of Kinesio Tape and High-intensity Laser Therapy in Lateral Epicondylitis N/A
Completed NCT05476445 - Effect of Cryotherapy and LLLT on Postoperative Pain After Root Canal Treatment N/A
Recruiting NCT05811026 - Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment N/A
Recruiting NCT05627141 - Photobiomodulation, Cryotherapy Combined With Compression, and Massage for Recovery N/A
Completed NCT01642693 - Histological Change of The Dentinal-Pulp Complex and Root Resorption Phase 1/Phase 2
Completed NCT04010929 - Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy N/A
Active, not recruiting NCT05596838 - Long-term Result of Placing Intracorneal Rings in Keratoconus Using Laser
Not yet recruiting NCT01735734 - Assessing the Effects of Air-cooling on Capillary Malformations N/A
Completed NCT04187053 - Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation Phase 4
Recruiting NCT03081130 - Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium N/A
Completed NCT03365167 - Clinical Evaluation of the Effect of LANAP as an Adjunct Treatment in Management of Patients With Chronic Periodontitis N/A
Recruiting NCT05793476 - Therapeutic Efficacy of Erbium:YAG Laser in Postpartum Patients With Episiotomy Scars N/A
Completed NCT03338517 - Helium-Neon Laser Therapy Versus Infrared Laser Therapy in Treating Patients With Diabetic Foot Ulcer N/A
Recruiting NCT06000202 - Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag Laser N/A
Recruiting NCT06038890 - The Learning Curve of Transurethral Holmium Laser Enucleation of the Prostate, Prospective Assessment N/A
Not yet recruiting NCT05299996 - Flexible URS in Management of Renal Stones in Anomalous Kidney N/A